PEOPLE - Molecular Insight Pharmaceuticals makes appointment:
This article was originally published in Clinica
Executive Summary
Former deputy commissioner for medical and scientific affairs at the US Centers for Medicare and Medicaid Services (CMS) Scott Gottlieb has become a board member at Molecular Insight Pharmaceuticals. The Cambridge, Massachusetts company will use his regulatory and reimbursement expertise as it develops its pipeline of molecular imaging pharmaceuticals and targeted radiotherapeutics for use in oncology and cardiology.